ArticleEFSA journal. European Food Safety Authority2021
Assessment of the 2019 post-market environmental monitoring report on the cultivation of genetically modified maize MON 810 in the EU.
Article in EFSA journal. European Food Safety Authority, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Scientific assessment of the 2024 post-market environmental monitoring report on the cultivation of genetically modified maize MON 810 in the EU.EFSA journal. European Food Safety Authority · 2026Article
- Assessment of the 2023 post-market environmental monitoring report on the cultivation of genetically modified maize MON 810 in the EU.EFSA journal. European Food Safety Authority · 2025Article
- Assessment of the 2022 post-market environmental monitoring report on the cultivation of genetically modified maize MON 810 in the EU.EFSA journal. European Food Safety Authority · 2024Article
- [Developmental toxicity of Cry1Ab protein in the embryonic stem-cell model].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2024Article
- Assessment of the 2021 post-market environmental monitoring report on the cultivation of genetically modified maize MON 810 in the EU.EFSA journal. European Food Safety Authority · 2023Article
- Assessment of the 2020 post-market environmental monitoring report on the cultivation of genetically modified maize MON 810 in the EU.EFSA journal. European Food Safety Authority · 2022Article
- Update of environmental risk assessment conclusions and risk management recommendations of EFSA (2016) on EU teosinte.EFSA journal. European Food Safety Authority · 2022Article
- Assessment of the 2019 post-market environmental monitoring report on the cultivation of genetically modified maize MON 810 in the EU.EFSA journal. European Food Safety Authority · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Following a request from the European Commission, the EFSA assessed the 2019 post-market environmental monitoring (PMEM) report on the cultivation of Cry1Ab-expressing maize event MON 810. Like previous years, there was full compliance with refuge requirement in Portugal and partial compliance with refuge requirements by Spanish farmers growing MON 810 varieties. European and Mediterranean corn borer populations collected from north-eastern Spain during the 2019 maize growing season and tested for Cry1Ab susceptibility show no symptoms of resistance to maize MON 810. The assessment of farmer questionnaires and relevant scientific publications does not indicate any unanticipated adverse effects on human and animal health or the environment arising from the cultivation of maize MON 810. Overall, EFSA concludes that the evidence reported in the 2019 PMEM report does not invalidate previous EFSA evaluations on the safety of maize MON 810. However, as in previous years, EFSA identifies shortcomings on resistance monitoring that need revision in future reports. In particular, the monitoring plan, as implemented in 2019, is not sufficiently sensitive to detect the recommended 3% resistance allele frequency. Consequently, EFSA strongly recommends the consent holder to achieve full compliance with refuge obligations in areas where adoption of maize MON 810 is high and increase the sensitivity of the monitoring plan by performing periodic F
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.